We are live on ! Find out more
MRTX

Mirati Therapeutics, Inc. Common Stock
MRTX

Delisted

MRTX was delisted on the 22nd of January, 2024.

Back to rankings

78 hedge funds and large institutions have $479M invested in Mirati Therapeutics, Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 31 increasing their positions, 15 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 15

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

92% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 13

38% more capital invested

Capital invested by funds: $346M → $479M (+$132M)

19% more call options, than puts

Call options by funds: $2.51M | Put options by funds: $2.1M

18% more funds holding

Funds holding: 66 → 78 (+12)

Holders
78
Holders Change
+12
Holders Change %
+18.18%
% of All Funds
2.18%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
25
Increased
31
Reduced
15
Closed
13
Calls
$2.51M
Puts
$2.1M
Net Calls
+$405K
Net Calls Change
+$395K

Top Buyers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
+$14.6M
2
ACA
Avoro Capital Advisors
New York
+$13.7M
3
VAM
Visium Asset Management
New York
+$12.8M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$11.1M
5
Citigroup
Citigroup
New York
+$10.3M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$13.3M
2
DM
Deerfield Management
New York
-$8.69M
3
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$5.11M
4
Franklin Resources
Franklin Resources
California
-$4.51M
5
First Eagle Investment Management
First Eagle Investment Management
New York
-$1.98M
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$2.81M +$64.2K +2,125 +3%
SFM
27
Sphera Funds Management
Israel
$2.75M -$453K -15,000 -16%
Jennison Associates
28
Jennison Associates
New York
$2.24M +$1.96M +65,000 New
SM
29
Sabby Management
Florida
$2.06M +$1.81M +60,000 New
SCM
30
Sio Capital Management
New York
$1.98M +$1.5M +49,597 +619%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$1.96M +$662K +21,885 +62%
RPAM
32
Rhenman & Partners Asset Management
Sweden
$1.72M – – –
BIM
33
BlackRock Investment Management
Delaware
$1.36M +$135K +4,473 +13%
TI
34
Trexquant Investment
Connecticut
$1.24M +$1.09M +36,100 New
GAMA
35
Graticule Asia Macro Advisors
New York
$1.24M +$1.09M +36,043 New
TCIM
36
TIAA CREF Investment Management
New York
$1.13M -$27.3K -903 -3%
CS
37
Credit Suisse
Switzerland
$1.05M +$923K +30,538 New
TC
38
TFS Capital
Pennsylvania
$1.05M +$920K +30,436 New
EI
39
EAM Investors
California
$868K -$409K -13,524 -35%
IAM
40
Integre Asset Management
New York
$835K +$7.92K +262 +1%
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$723K +$84.6K +2,800 +15%
RFC
42
Russell Frank Company
Washington
$693K -$413K -13,647 -40%
TAM
43
Tocqueville Asset Management
New York
$687K +$174K +5,750 +40%
PP
44
PDT Partners
New York
$640K +$292K +9,648 +108%
Millennium Management
45
Millennium Management
New York
$636K +$558K +18,472 New
BI
46
Boulegeris Investments
Georgia
$628K +$24.9K +825 +5%
ACH
47
ArrowMark Colorado Holdings
Colorado
$589K +$518K +17,122 New
UBS Group
48
UBS Group
Switzerland
$575K -$49.5K -1,636 -9%
Swiss National Bank
49
Swiss National Bank
Switzerland
$554K +$227K +7,500 +87%
BPGAM
50
BTG Pactual Global Asset Management
Bermuda
$516K +$453K +15,000 New
1
2
3 4

MRTX Hedge Fund Activity: Q3 2015 in Review

78 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Mirati Therapeutics, Inc. Common Stock (MRTX) for Q3 2015, worth a combined $479M — up 38% from $346M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new MRTX positions and 13 closed out — a net gain of 12 holders — while 31 added to existing stakes and 15 trimmed.

The largest buyer was RTW Investments, opening a new position worth an estimated $14.6M. The largest seller was OrbiMed, cutting an estimated $13.3M.

  • 78 institutional investors held Mirati Therapeutics, Inc. Common Stock (MRTX) as of Q3 2015, up from 66 in Q2 2015.
  • Funds reported $479M of Mirati Therapeutics, Inc. Common Stock stock for Q3 2015, up 38% quarter-over-quarter.
  • 25 funds opened new Mirati Therapeutics, Inc. Common Stock positions in Q3 2015 and 13 closed out, a net change of +12 holders.
  • The largest Mirati Therapeutics, Inc. Common Stock buyer in Q3 2015 was RTW Investments, an estimated $14.6M added.
  • The largest Mirati Therapeutics, Inc. Common Stock seller in Q3 2015 was OrbiMed, an estimated $13.3M sold.

Based on aggregated 13F filings for Q3 2015.